The post KindlyMD board approves share repurchase program for Bitcoin operations appeared on BitcoinEthereumNews.com. Key Takeaways KindlyMD’s board has approvedThe post KindlyMD board approves share repurchase program for Bitcoin operations appeared on BitcoinEthereumNews.com. Key Takeaways KindlyMD’s board has approved

KindlyMD board approves share repurchase program for Bitcoin operations

Key Takeaways

  • KindlyMD’s board has approved a share repurchase program to support its Bitcoin operations.
  • The initiative reflects confidence in KindlyMD’s long-term digital asset strategy.

KindlyMD a provider of integrated healthcare services and parent company of Bitcoin-focused Nakamoto Holdings, has authorized a share repurchase program to buy back its outstanding common stock.

The repurchases may be conducted through open-market purchases, private transactions, block trades, and other permissible methods. The company may also use Rule 10b5-1 trading plans, with all buybacks subject to Rule 10b-18 of the Securities Exchange Act.

Management will determine the timing and amount of buybacks based on market conditions, capital needs, trading volume, and regulatory factors. The program does not commit KindlyMD to repurchase any specific number of shares and may be adjusted or discontinued at any time.

Source: https://cryptobriefing.com/share-repurchase-bitcoin-operations/

Market Opportunity
Belong Logo
Belong Price(LONG)
$0.00616
$0.00616$0.00616
-2.88%
USD
Belong (LONG) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.